ClinicalTrials.gg
CompletedNCT07887035Updated Oct 21, 2026

Reiki After Bariatric Surgery

An interventional study of reiki and Sham Reiki in Nausea and Vomitting, Distension; Bowel and Pain, sponsored by TC Erciyes University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by TC Erciyes University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Nov 2025, registered Oct 2026).
Updated Oct 21, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this clinical trial was to determine whether Reiki administered to patients after bariatric surgery reduced abdominal distension, nausea and vomiting, and pain severity, and improved their comfort levels. The primary research questions were as follows:

Does Reiki reduce abdominal distension, nausea and vomiting, and pain severity? Does Reiki improve patient comfort? The researchers compared Reiki with sham Reiki (a procedure designed to resemble Reiki) and routine care. Seventy-five patients were assigned to one of the three groups using stratified randomization according to age and sex.

Participants: For three days after bariatric surgery, participants received one session of Reiki, one session of sham Reiki, or routine care and completed questionnaires assessing abdominal distension, nausea and vomiting, pain, and comfort.

Read the detailed description

Bariatric surgery may lead to abdominal distension, nausea and vomiting, increased pain severity, and decreased comfort. This study examined the effects of Reiki administered after bariatric surgery on patients' abdominal distension, nausea and vomiting, pain, and comfort levels.

The study was conducted between November 2025 and March 2026 at a city training and research hospital in Türkiye. Seventy-five patients who underwent bariatric surgery were assigned to one of three groups using stratified randomization according to age and sex: the Reiki group (n = 25), the sham Reiki group (n = 25), and the routine care group (n = 25).

Patients in the Reiki group received one session of Level 1 Reiki, lasting approximately 30 minutes, on postoperative day 0, four hours after analgesic administration. Reiki was administered through touch at nine specific points on the body. Patients in the sham Reiki group received a procedure designed to mimic Reiki, whereas those in the control group received routine care without any additional intervention. The assigned procedures were repeated on postoperative days 1 and 2, and the intervention period lasted three days.

The researchers assessed abdominal distension, nausea and vomiting, pain, and comfort using questionnaires. In addition, only the index of nausea, vomiting and retching was administered by telephone on the evening of postoperative day 3, after the patients had been discharged. Clarify the intervention schedule Specify the study design.

02

Conditions studied

  • Nausea and Vomitting
  • Distension; Bowel
  • Pain
  • Comfort

Keywords

  • Nausea
  • vomitting
  • distension
  • pain
  • comfort
  • bariatric surgery
  • care
  • reiki
03

In context

Nausea

840 studies on the registry are indexed under Nausea; 106 are open to participants now.

This study's enrollment of 75 is below the median of 115 across 716 interventional studies indexed under Nausea.

Browse Nausea studies →

Lead sponsor

TC Erciyes University is the lead sponsor of 346 studies on the registry; 76 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who underwent laparoscopic bariatric surgery (sleeve gastrectomy).
  • Aged 18 years or older.
  • No visual or hearing impairments.
  • Able to speak Turkish and communicate verbally.
  • Body mass index (BMI) ≥ 35 kg/m².
  • At least four hours had elapsed since the last analgesic administration.
  • No diagnosed psychiatric disorders.
  • Pain intensity score of ≥ 3 on the Numerical Rating Scale (NRS) in each group.
  • Patients transferred to the postoperative ward.
  • Willingness to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Patients taking psychiatric medications.
  • Patients with open wounds.
  • Patients with cardiac arrhythmias.
  • Patients with a pacemaker.
  • Patients with chronic pain who were taking opioid medications.
  • Patients who practiced or taught Reiki.
  • Patients who had received training in energy therapies (e.g., Reiki or Therapeutic Touch).
  • Patients using another complementary and integrative therapy (CIT) modality.
  • Patients whose surgery lasted longer than 2 hours.
  • Patients who spent postoperative day 0 in the intensive care unit.
  • Patients who underwent revision surgery.
  • Individuals who participated in the pilot study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
75 participants (actual)

Study arms

  • Experimental
    Reiki group

    Reiki Group participants who underwent bariatric surgery received a 30-minute Level 1 Reiki session administered by a researcher trained and experienced in the Usui method, four hours after analgesic administration.

    Other: reiki

  • Placebo comparator
    Sham reiki

    Sham Reiki Group participants who underwent bariatric surgery received a single 30-minute sham Reiki session four hours after analgesic administration. The session was administered by an individual who had not received Reiki training or Reiki attunement. The procedure was presented to participants as Reiki.

    Other: Sham Reiki

  • No intervention
    Control

    Routine care

Interventions

  • Otherreiki

    Participants received a single 25-30-minute Level 1 Reiki session targeting nine specific areas of the body. The session was conducted four hours after analgesic administration following bariatric surgery by a researcher who had received Reiki attunement, in accordance with the study protocol.

  • OtherSham Reiki

    Sham Reiki in addition to routine care, participants received a 25-30-minute sham Reiki session targeting nine specific areas of the body, administered four hours after analgesic administration following bariatric surgery. In accordance with the study protocol, the session was conducted by Interviewer 2, who had not received Reiki training.

06

What researchers measure

Primary outcomes

  1. Nausea and Vomitting

    Nausea was assessed using the Rhodes Index of Nausea, Vomiting, and Retching (INVR). The maximum possible score is 32, with higher scores indicating more severe nausea, vomiting, and retching symptoms.

    Time frame: Before Reiki administration and on postoperative days 0, 1, and 2. On the evening of discharge, the scale was administered by telephone on postoperative day 3.

  2. Pain

    The Numerical Rating Scale (NRS) was used to assess pain intensity. Participants were informed that "0" represented "no pain at all," that pain intensity increased as the numbers increased, and that "10" represented "unbearable pain." They were then asked to select the number that best represented their pain intensity.

    Time frame: Twice daily (before and after the intervention) for three postoperative days.

  3. Distension

    The Numerical Rating Scale (NRS) was used to assess abdominal distension. Participants were informed that "0" represented "no abdominal distension," that the severity of abdominal distension increased as the numbers increased, and that "10" represented "the most severe abdominal distension imaginable." They were then asked to select the number that best represented their perceived level of abdominal distension.

    Time frame: Twice daily (before and after the intervention) for three postoperative days.

  4. Comfort

    Patient comfort was assessed using the General Comfort Questionnaire (GCQ). The maximum possible total score is 192, and the minimum is 48.

    Time frame: Twice daily (before and after the intervention) for three postoperative days.

07

Study locations

1 site
  • Adana City Training and Research Hospital
    Adana, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2025 to primary completion in Mar 2026, 4 months.

Of 174 non-industry interventional studies with no phase under Nausea, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 24. This study's 4 months is below that.

Counting every sponsor, half of 177 studies reached it within 12 months; a quarter within 6 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2026
First posted
Oct 21, 2026
StartActual
Nov 1, 2025
Primary completionActual
Mar 31, 2026
CompletionActual
Mar 31, 2026
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07887035
Responsible party
Hatice Ciftci (PhD student, TC Erciyes University) — Principal investigator
First posted
Oct 21, 2026
Start date
Nov 1, 2025
Primary completion
Mar 31, 2026
Completion
Mar 31, 2026
Last update
Oct 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion